LIN Q3 2026 Earnings Analysis
Linde reported Q3 record sales of $9.4B and EPS of $4.59 with 9% growth, announced $425M restructuring, and guided Q4 EPS of $4.40-$4.50 as it addresses non-gas segment headwinds and Lincare challenges.
Key Metrics
Points clés
- Record Q3 sales of $9.4B and EPS of $4.59, but margin flat ex cost pass-through from non-gas headwinds.
- $425M restructuring announced: half severance, half portfolio actions mainly in Lincare home care business.
- Electronics segment grew 15% in APAC/U.S.; $2B projects under construction supporting future double-digit growth.
Écouter sur
Disponible en
Transcript
// Full episode scriptWelcome to Beta Finch, your AI-powered earnings breakdown, where we turn dense earnings calls into conversations you'd actually want to have over coffee. I'm Alex.
And I'm Jordan. Today we're digging into Linde — ticker LIN — the industrial gas giant, reporting Q3 2026 results.
Before we get into it, quick note: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.
Got it. So Alex, let's set the scene. Three months ago, Linde's management basically admitted their numbers weren't great. CEO Sanjiv Lamba opened this call by saying the message was "received loud and clear." That's a pretty candid admission for a company this size.
Right, and they backed it up with action — a $425 million restructuring charge this quarter. Roughly half of that is severance, mostly in slower-growth regions. The other half is tied to portfolio moves, primarily around their U.S. home care business, Lincare.
Lincare's the name that's going to come up a lot today. But first, let's talk headline numbers because on the surface, this was actually a record quarter.
Yeah — sales of $9.4 billion, up 9% year-over-year. Operating profit hit $2.8 billion, and EPS came in at $4.59, up 9%. All quarterly records.
But — and this is the "yeah, but" moment — operating margin excluding cost pass-through was basically flat. So revenue's growing, profits are growing, but the underlying profitability engine isn't really improving yet.
Right, and management was upfront that non-gas segments — meaning Lincare and the Engineering business — are the drag. The core gas business is healthy; it's the stuff around the edges weighing things down.
Let's talk about where growth is actually coming from, because it's pretty concentrated. Electronics was the star — 15% growth, driven by Asia-Pacific and the U.S. And get this: they've got about $2 billion of electronics projects under construction right now in the U.S., Korea, and China.
That's a serious pipeline. CEO Lamba basically said he expects double-digit electronics growth to continue for the next few years because of that backlog alone.
Chemicals & Energy also grew 12%, helped by stronger volumes in the U.S. and China, plus some interesting geopolitical tailwinds — customers on the Gulf Coast and in China are benefiting from raw material advantages tied to the Middle East conflict.
Meanwhile, Europe remains... let's say "uninspiring." Lamba didn't sugarcoat it — he said there's "zero catalyst" for European industrial recovery right now. No pragmatic policy action, high energy costs, and no sign domestic demand is picking up anytime soon.
And it's a similar story in China, interestingly. Exports are strong, but domestic consumption — including EV purchases, which were down 11-12% — just isn't showing up. Electronics is really the one bright spot there too.
Now let's get to Lincare, because this is the headline strategic story. Starting this quarter, Lincare now reports directly to CFO Matt White instead of sitting in the regional Americas segment, and it's been moved into the "Global Other" category.
Which sounds like a filing cabinet move, but it's actually significant. It increases executive oversight and, frankly, makes the core Gases business numbers cleaner for investors to evaluate — because Lincare's been dragging on results.
CFO Matt White said Lincare is costing the company about 1.5 to 2 percentage points of EPS growth this year. Strip that out, and Linde would be back in double-digit EPS growth territory.
And when analysts pushed on whether this means a sale is coming, management was careful — they said they're "evaluating strategic options" but can't guarantee there will be one. The priority right now is just running the business better.
It's actually a bit of corporate déjà vu — White referenced their old GIST business, which went through a similar reclassification process years ago before eventually being sold.
Let's touch on pricing, because that was a hot topic in Q&A. Americas pricing was up 6%, way ahead of other regions. Management explained about 2 points of that was catch-up recovery for distribution and energy cost inflation that hit faster than expected.
And there's a quirk here too — pulling Lincare out of the Americas segment math makes the pricing numbers there look even more pronounced, since the denominator got smaller.
Smart context for investors to keep in mind before assuming pricing power suddenly spiked overnight.
Other fun detail: helium. Qatar supply is expected to only reach about 75% of normal production next year due to Strait of Hormuz logistics challenges. Linde's been managing it well — they moved 340 helium containers globally last quarter alone — but Lamba was candid that nobody really knows when that geopolitical situation resolves.
Now, guidance. Fourth quarter EPS guide is $4.40 to $4.50, which is actually a deceleration — 5-7% growth versus the 9% they just posted.
Management broke that down: about 1% is FX headwind, 1% is a one-time equity income item rolling off, and the last point is just conservatism — they're not assuming any economic improvement, and they're being cautious on Lincare's near-term trajectory.
Full-year guidance is $17.82 to $17.92 — basically just adding Q4 to year-to-date actuals. Nothing dramatically bullish, nothing alarming.
So what's the investor takeaway here, Jordan?
I'd frame it as: the core industrial gas business is solid and even accelerating in pockets like electronics and U.S. chemicals. But Linde is actively cleaning house — restructuring costs, repricing to beat inflation, and ring-fencing a problem child in Lincare so it doesn't keep muddying the picture.
It's a "show me" story for the next couple of quarters — watch for whether pricing actions actually translate to margin expansion, and keep an eye on Lincare headlines for any strategic review updates.
Before we wrap — everything discussed is AI-generated analysis for educational purposes. Past performance doesn't guarantee future results. Please do your own due diligence.
Well said. Linde management says they'll give more detailed 2027 guidance in February, so we'll be watching for that.
Until then, this has been Beta Finch.
Thanks for listening — we'll see you next time.